Transcatheter Pulmonary Valve Market by Technology and Geography - Forecast and Analysis 2022-2026

The transcatheter pulmonary valve market share is expected to increase by USD 51.74 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.1%.

This transcatheter pulmonary valve market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers transcatheter pulmonary valve market segmentations by technology (balloon-expanded and self-expanded) and geography (North America, Europe, Asia, and Rest of World (ROW)). The transcatheter pulmonary valve market report also offers information on several market vendors, including Abbott Laboratories, Artivion Inc., Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc., Medtronic Plc, Venus Medtech Hangzhou Inc., and Xeltis AG among others.

What will the Transcatheter Pulmonary Valve Market Size be During the Forecast Period?

Download Report Sample to Unlock the Transcatheter Pulmonary Valve Market Size for the Forecast Period and Other Important Statistics

 

Transcatheter Pulmonary Valve Market: Key Drivers, Trends, and Challenges

The rising incidence of cardiac diseases is notably driving the transcatheter pulmonary valve market growth, although factors such as a shortage of cardiologists may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the transcatheter pulmonary valve industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Transcatheter Pulmonary Valve Market Driver

• The rising incidence of cardiac diseases is one of the factors driving the transcatheter pulmonary valve market growth.
• According to NIH, in 2020, the degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation were found in nearly 10% of the population aged 75 years and above. Therefore, with the expanding aging population base in developed as well as developing countries, the prevalence of heart diseases will likely increase.
• The prevalence of heart valve diseases is rising due to the increased life expectancy in the elderly population. 
• Heart valve disease is one of the most serious and common valve diseases and is likely to increase with advancing age. Thus, the growing prevalence of heart valve diseases such as CHD, aortic stenosis, and mitral heart valve diseases is likely to increase the demand for TPV.
• With the increasing number of hypertension cases in the country, the number of Medicare providers such as hospitals and clinics are growing. Such factors are expected to drive the growth of the global TPV market during the forecast period.

Key Transcatheter Pulmonary Valve Market Trend

• Favorable reimbursement policies is one of the key transcatheter pulmonary valve market trends fueling the market growth.
• The rise of the TPV market has been aided by a variety of healthcare aids.
• Medicare, the US national social insurance program, reimburses individuals whose aortic heart valves are damaged and require replacement.
• The FDA and the Centers for Medicare and Medicaid Services (CMS) have jointly authorized insurance coverage for transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis since 2012. Thus, these initiatives are expected to propel market growth in the coming years.

Key Transcatheter Pulmonary Valve Market Challenge

• A shortage of cardiologists is one of the factors hindering the transcatheter pulmonary valve market growth.
• Knowledge and skills in handling and using diagnostic and therapeutic tools play a major role in the early diagnosis and treatment of diseases. 
• The lack of expertise increases the probability of misdiagnosis and improper treatment care, which can cause harm to patients. However, the market has a shortage of skilled cardiologists for performing heart valve surgical interventions. Factors such as the migration of well-trained specialists from developing countries to developed countries are responsible for this shortage.
• The increasing rates of burned-out professionals lead to the shortage of skilled professionals. Thus, the shortage of cardiologists can hinder the growth of the global TPV market during the forecast period.

This transcatheter pulmonary valve market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global transcatheter pulmonary valve market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the transcatheter pulmonary valve market during the forecast period.

Who are the Major Transcatheter Pulmonary Valve Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• Abbott Laboratories
• Artivion Inc.
• Boston Scientific Corp.
• Braile Biomedica
• Colibri Heart Valve LLC
• Edwards Lifesciences Corp.
• JenaValve Technology Inc.
• Medtronic Plc
• Venus Medtech Hangzhou Inc.
• Xeltis AG

 

This statistical study of the transcatheter pulmonary valve market encompasses successful business strategies deployed by the key vendors. The transcatheter pulmonary valve market is fragmented and the vendors are deploying growth strategies such as mergers and acquisitions to compete in the market.

Product Insights and News

• abbott.com - The company offers transcatheter pulmonary valve namely MitraClip TMVr System.
• artivion.com - The company offers transcatheter pulmonary valve namely CryoValve SG.
• bostonscientific.com - The company offers transcatheter pulmonary valve namely LOTUS Edge valve system.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The transcatheter pulmonary valve market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Transcatheter Pulmonary Valve Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the transcatheter pulmonary valve market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Transcatheter Pulmonary Valve Market?

For more insights on the market share of various regions Request PDF Sample now!

43% of the market’s growth will originate from North America during the forecast period. The US is the key market for the transcatheter pulmonary valve market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The presence of a highly developed healthcare sector, as well as the rising prevalence of disorders such as pulmonary stenosis and regurgitation, will facilitate the transcatheter pulmonary valve market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In early 2020, the outbreak of COVID-19 in the region led to a halt in the operations of units manufacturing surgical instruments, including TPV. However, the market in North America is expected to witness moderate growth during the forecast period owing to increasing healthcare spending from the middle-class and upper-middle-class population in the US.

What are the Revenue-generating Technology Segments in the Transcatheter Pulmonary Valve Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The transcatheter pulmonary valve market share growth in the balloon-expanded segment will be significant during the forecast period. The balloon-expanded segment in the global TPV market is expected to witness significant growth in terms of market revenue compared with self-expanded segments during the forecast period. This is due to the increase in the adoption of balloon-expanded TPV and the increase in the prevalence of chronic diseases, such as aortic stenosis and cardiovascular disease, across the globe. Furthermore, the process and recuperation times for balloon-expanded TPV are faster and simpler. Such factors are expected to propel the demand for the balloon-expanded segment, which will fuel the growth of the global TPV market during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the transcatheter pulmonary valve market size and actionable market insights on post COVID-19 impact on each segment.

 

Transcatheter Pulmonary Valve Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 6.1%
Market growth 2022-2026	$ 51.74 million
Market structure	Fragmented
YoY growth (%)	5.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 43%
Key consumer countries	US, Germany, UK, France, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Artivion Inc., Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc., Medtronic Plc, Venus Medtech Hangzhou Inc., and Xeltis AG
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Transcatheter Pulmonary Valve Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive transcatheter pulmonary valve market growth during the next five years
• Precise estimation of the transcatheter pulmonary valve market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the transcatheter pulmonary valve industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of transcatheter pulmonary valve market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch